Telmisartan 是一种血管紧张素II受体拮抗剂(ARB),用于治疗高血压。
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Benson SC, et al. Hypertension, 2004, 43(5), 993-1002.
[2] Rong et al (2009) An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice. J.Pharmacol.Exp.Ther. 331 1096.
[3] Ries et al (1993) 6-substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships. J.Med.Chem. 36 4040.
分子式 C33H30N4O2 |
分子量 514.62 |
CAS号 144701-48-4 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 13 mg/mL |
Water Insoluble |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01356017 | Healthy Male Volunteers | Drug: Telmisartan 80mg, S-amlodipine 5mg|Drug: Telmisartan 80mg | Chong Kun Dang Pharmaceutical|Asan Medical Center | Phase 1 | 2011-06-01 | 2011-09-04 |
NCT02338232 | GVHD | Drug: Telmisartan | Hackensack University Medical Center | 2015-06-01 | 2016-12-28 | |
NCT01211171 | Hypertension | Drug: Telmisartan (Kinzal/Pritor, BAY68-9291) | Bayer | 2009-05-01 | 2014-02-11 | |
NCT02170246 | Acute HIV Infection|HIV Infections | Drug: Telmisartan | Yale University|National Institute of Neurological Disorders and Stroke (NINDS)|South East Asia Research Collaboration with Hawaii|University of California, San Francisco|Walter Reed Army Institute of Research (WRAIR)|University of Hawaii|National Institute of Mental Health (NIMH) | Phase 1 | 2014-08-01 | 2015-01-22 |
NCT01842230 | Essential Hypertension|Hyperlipidemia | Drug: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg|Drug: Telmisartan 80mg and S-amlodipine 5mg | Chong Kun Dang Pharmaceutical | Phase 1 | 2013-04-01 | 2013-07-31 |
NCT01181011 | Healthy | Drug: amlodipine/telmisartan/combination | Boehringer Ingelheim | Phase 1 | 2010-08-01 | 2014-07-15 |
NCT01088295 | HIV Infection | Drug: Telmisartan | University of California, Los Angeles|California HIV/AIDS Research Program | Phase 2 | 2010-05-01 | 2014-06-19 |
NCT01806363 | Hypertension | Drug: Telmisartan 80mg|Drug: Chlorthalidone 25mg | HanAll BioPharma Co., Ltd. | Phase 1 | 2012-11-01 | 2014-02-24 |
NCT01578772 | Endothelial Dysfunction | Drug: Telmisartan | University of California, Los Angeles|The Campbell Foundation | Phase 2 | 2012-08-01 | 2014-12-02 |
NCT02213224 | Nonalcoholic Fatty Liver Disease (NAFLD) | Drug: Perindopril|Drug: Telmisartan|Drug: Amlodipine | Nanfang Hospital of Southern Medical University | Phase 4 | 2014-08-01 | 2014-08-08 |
NCT00471003 | Hypertension | Drug: Pritor (Telmisartan , BAY68-9291) | Bayer | 2006-09-01 | 2010-01-19 | |
NCT02079805 | Essential Hypertension Complicated by Type 2 Diabetes Mellitus | Drug: Azilsartan|Drug: Telmisartan | Takeda | Phase 4 | 2014-03-01 | 2016-07-26 |
NCT02259816 | Healthy | Drug: Telmisartan|Drug: Amlodipine | Boehringer Ingelheim | Phase 1 | 2006-05-01 | 2014-10-06 |
NCT02057328 | Hypertension | Drug: TELMISARTAN|Drug: NEBIVOLOL | Aristotle University Of Thessaloniki | Phase 4 | 2010-12-01 | 2014-02-05 |
NCT01217879 | Hypertension | Drug: Telmisartan (Kinzal/Pritor, BAY68-9291) | Bayer | 2010-01-01 | 2012-11-14 | |
NCT02262559 | Healthy | Drug: BIBR 277 tablet|Drug: BIBR 277 capsule | Boehringer Ingelheim | Phase 1 | 2002-07-01 | 2014-10-09 |
NCT01928927 | HIV-1 Infection | Drug: Telmisartan | AIDS Clinical Trials Group|National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2013-11-01 | 2016-05-05 |
NCT01975961 | Dyslipidemia & Hypertension | Drug: Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC | Yuhan Corporation | Phase 1 | 2013-07-01 | 2013-10-28 |
NCT02750059 | Acute HIV Infection|HIV CNS Involvement | Drug: TDF/3TC/EFV + Telmisartan|Drug: TDF/3TC/EFV only | South East Asia Research Collaboration with Hawaii|National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 | 2015-01-01 | 2016-12-07 |
NCT01683084 | Abdominal Aortic Aneurysm | Drug: Telmisartan|Drug: Placebo | Ronald L. Dalman, MD|Palo Alto Veterans Institute for Research | Phase 4 | 2012-09-01 | 2016-03-28 |
NCT02047175 | Hypertension|Hyperlipidemia | Drug: Telmisartan/S-Amlodipine|Drug: Rosuvastatin|Drug: Telmisartan/S-Amlodipine + Rosuvastatin|Drug: Telmisartan/S-Amlodipine + Rosuvastatin | Chong Kun Dang Pharmaceutical | Phase 1 | 2014-02-01 | 2014-04-16 |
NCT02187705 | Hypertension | Drug: Telmisartan tablets | Boehringer Ingelheim | Phase 4 | 1999-05-01 | 2014-07-10 |
NCT01222520 | Hypertension | Drug: Telmisartan and amlodipine|Drug: Telmisartan | Boehringer Ingelheim | Phase 3 | 2010-10-01 | 2014-06-17 |
NCT00559286 | Arterial Hypertension|Diabetes Mellitus Type 2 IRC or NIR | Drug: Telmisartan | RWTH Aachen University|CTCA|Heidelberg University|Bayer | Phase 4 | 2007-12-01 | 2009-01-28 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们